
|Articles|November 28, 2012
Protein predicts post-RP cancer recurrence, death
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent report.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
FDA approves IsoPSA test as aid in the diagnosis of high-grade prostate cancer
3
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
4
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
5


















